Treasurer of the State of North Carolina’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Treasurer of the State of North Carolina’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-9,590	Closed	-$956K	–	1074
2021 Q1	$956K	Buy	9,590 +750	+8%	+$87.5K	0.01%	964
2020 Q4	$1.09M	Buy	8,840 +20	+0.2%	+$2.63K	0.01%	922
2020 Q3	$859K	Buy	8,820 +120	+1%	+$15K	0.01%	918
2020 Q2	$1.36M	Buy	+8,700	New	+$1.32M	0.01%	813

Other funds holding RETA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Treasurer of the State of North Carolina's RETA Position: Q2 2021 in Review

Treasurer of the State of North Carolina sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q2 2021, closing a stake of 9,590 shares — an estimated $956K sold.

Treasurer of the State of North Carolina first reported a position in RETA in Q2 2020 and held it in 4 quarters. The position peaked at $1.36M in Q2 2020. 194 funds tracked by Wall St. Rank hold RETA as of Q2 2021.

Treasurer of the State of North Carolina reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q2 2021 after selling out during the quarter.
Treasurer of the State of North Carolina sold 9,590 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q2 2021, an estimated $956K.
Treasurer of the State of North Carolina first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q2 2020 and held it in 4 quarters.
Treasurer of the State of North Carolina's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $1.36M in Q2 2020.
194 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q2 2021.

Based on Treasurer of the State of North Carolina's 13F filing for Q2 2021, filed 13 Aug 2021.